The Effect of Grape Consumption on Increasing the Good Bacteria in the Human Intestine

NCT ID: NCT05025189

Last Updated: 2023-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-05

Study Completion Date

2021-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study will assess the ability of daily consumption of one dose (2 servings) of freeze-dried whole table grape powder, made from conventionally grown grapes to alter the composition of the bacteria that live in the intestines in healthy subjects. The grape powder contains 46g of individually quick frozen (IQF) grapes, which is equivalent to 252g fresh fruit. 20 subjects will will consume the beige diet for 4 weeks followed by one dose (two servings) of standardized Freeze-Dried Whole Table Grape Powder (46g) daily for 4 weeks. The primary objective of this pilot study is to determine changes in the gut microbiome. Stool samples will be collected at 4 and 8 weeks for bacterial DNA to determine changes in the bacteria that live in the intestines. You will be asked to avoid foods rich in polyphenols including dark chocolate and cocoa products, dried herbs, berries, coffee, tea, flaxseeds, nuts (chestnut, hazelnut), olive and artichoke for the duration of the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The bacterial composition of the intestinal microbiome has been linked to the development of chronic diseases including obesity, metabolic syndrome, type II diabetes and heart disease. Grapes provide a rich source of polyphenols and fiber. It has been demonstrated in animal studies that fruits with high polyphenol content and fiber exhibit prebiotic effects leading to changes in the gut microbiome, decrease in symptoms of metabolic syndrome, improvement in insulin resistance and decrease in intestinal and systemic inflammation. Several human intervention studies have also been performed that demonstrated beneficial effects of high polyphenol fruits on the intestinal microbiome. No information is available about the effect of grape consumption on the gut microbiome. This proposed pilot study will assess the ability of consumption of two servings of grapes daily to alter the gut microbiome composition, leading to increased bile secretion, increased fecal cholesterol degradation/excretion, decreased plasma cholesterol and improved intestinal wellbeing in a free-living population. 20 subjects will consume the beige diet for 4 weeks followed by one dose (two servings) of standardized Freeze-Dried Whole Table Grape Powder (46g) daily for 4 weeks. The primary objective of this pilot study is to determine changes in the gut microbiome. Secondary outcome will be fecal bile and cholesterol and their metabolites, plasma cholesterol and intestinal wellbeing questionnaire at 4 and 8 weeks Stool samples will be collected at 4 and 8 weeks for sequencing of bacterial DNA to determine changes in the microbiota. Changes in fecal bile, cholesterol, and cholesterol metabolites will be analyzed by gas chromatography. The objective of the proposed pilot study is to determine whether intake of 2 servings of grapes per day will alter the intestinal microflora leading to an increase in intestinal cholesterol degradation, decreased plasma cholesterol and increased intestinal wellbeing. This project will provide novel preliminary data for future research studies and to develop new consumer messages on the gut health benefits of grapes. New consumer information about the health benefit of grapes will enhance the The California Table Grape industry domestic and export marketing programs and increase consumption of grapes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

This will be a two phase intervention study.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Table Grape

Subjects will consume 4 weeks of (two servings) of standardized Freeze-Dried Whole Table Grape Powder

Group Type ACTIVE_COMPARATOR

Table Grape Powder

Intervention Type OTHER

Freeze Dried Whole Table Grape Powder

Beige Diet

Subjects will consume 4 weeks of a beige diet (low in fiber and low in polyphenols)

Group Type PLACEBO_COMPARATOR

Beige Diet

Intervention Type OTHER

Low Fiber, low polyphenol Diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Table Grape Powder

Freeze Dried Whole Table Grape Powder

Intervention Type OTHER

Beige Diet

Low Fiber, low polyphenol Diet

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy human adults age 18-55 years old (females have to be premenopausal)
* Typically consume low fiber/polyphenol diet (beige diet)

Exclusion Criteria

* Eating a high fiber/polyphenol diet or taking any medication or dietary supplement, which interfere with the absorption of polyphenols.
* History of gastrointestinal surgery, diabetes mellitus on medications, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP \>160mmHg, diastolic BP \> 95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, laxative abuse, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history or routine physical examination.
* Screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
* Is unable or unwilling to comply with the study protocol.
* Using prebiotics, probiotics, yogurt, and/or any fiber supplements regularly
* Allergy or sensitivity to grapes. Subjects will be excluded if there is a prior history of such sensitivity. Since these foods are commonly eaten and allergies are rare, subjects should be aware of this sensitivity prior to entering the study. To determine this, a positive affirmation by the subject of grape ingestion without incident will be requested.
* Taking antibiotics or laxatives within the past 3 months
* Allergy or sensitivity to grapes. Subjects will be excluded if there is a prior history of such sensitivity. Since these foods are commonly eaten and allergies are rare, subjects should be aware of this sensitivity prior to entering the study. To determine this, a positive history of grape ingestion without incident will be requested. In addition, any subject with a history of allergy or anaphylaxis of any kind will be excluded
* Subjects with known allergy to food coloring dyes.
* In the opinion of the study investigator, any subject who demonstrate a risk of non-compliance with study procedure, or one who cannot read, understand or complete study - related materials.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The California Table grape Commission

OTHER

Sponsor Role collaborator

University of California, Los Angeles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhaoping Li

Chief, Division of Clinical Nutrition

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhaoping Li, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

UCLA Center for Human Nutrition

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCLA Center for Human Nutrition

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-001635

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Yogurt and GI Health
NCT05931471 COMPLETED NA
Probiotics to Promote Intestinal Health
NCT02046512 COMPLETED PHASE4